商標ウォッチ

TOP｜特許｜意匠｜商標

商標ウォッチ Twitter

公開日2024-05-15
公報種別公開国際商標公報
国際登録番号1780091
国際登録日2024-01-10
区分第5類(薬剤),第44類(医療・農林業)
商品役務Cell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors.,Cell therapy medical treatment services; immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient’s white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient.
基礎出願番号UK00003967989
基礎出願日2023-10-16
基礎出願国GB
出願人Adaptimmune Limited
OCRテキスト< Tecelra
OCRテキスト2Tecelra
OCRについて

この商標をJ-PlatPatで参照する

関連商標

Professional Dietetics S.p.A.

Novo Nordisk A/S

TerraPower, LLC

tpi TERRAPOWER ISOTOPES

Lantheus Medical Imaging, Inc.

Lantheus Medical Imaging, Inc.

KAMUT ENTERPRISES OF EUROPE, BV

KAMUT BRANDWHEAT

Premier Foods Group Limited

Dyne Therapeutics, Inc.

DYNETHERAPEUTICS

OLIVIT Sp. z o.o.

ARROWHEAD PHARMACEUTICALS, INC.

Novo Nordisk A/S

ZEALAND PHARMA A/S

Orion Corporation

DR.ANKERSTJERNE AS

Dr.StineAnkerstjerne

DR.ANKERSTJERNE AS

DR.STINE ANKERSTJERNE

Consumer Innovation AG

Straumann Holding AG

Neurocrine Biosciences, Inc.

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH

POOLBEG PHARMA (UK) LIMITED

続きを見る